BayWa’s €107 Million Lifeline Arrives as Banks Weigh a Historic €1 Billion Haircut

BayWa's €107M Cefetra sale provides short-term cash but leaves a €2.7B debt gap; creditors face write-off demands as renewable unit struggles.

The clock is ticking louder for BayWa. On April 30, the embattled German agribusiness and renewables group will pocket roughly €107 million from the sale of its Dutch subsidiary Cefetra — €45 million in residual purchase price and €62 million from repaid shareholder loans. The transaction, closed operationally in the first quarter of 2026, hands management a short-term cash buffer. But it does nothing to close the yawning gap that threatens to swallow the company whole.

That gap is staggering. BayWa has already shed 1.3 billion euros in debt through asset disposals, yet its total liabilities still stand at around 4.7 billion euros. The target is to slash that to two billion by 2028 — a chasm of roughly 2.7 billion euros that no single sale can fill. Now, the company’s largest shareholders, led by the Bayerische Raiffeisen-Beteiligungsaktiengesellschaft, are demanding that creditors accept a write-off of approximately one billion euros. In exchange, they are dangling betterment certificates that would allow banks to recoup some value if the recovery succeeds.

The decision rests squarely with BayWa’s core lenders: DZ Bank and UniCredit/HVB. Without their agreement to extend the standstill pact through autumn 2026, the restructuring framework established under the StaRUG procedure in May 2025 loses its legal footing. A collapse of that framework would send the entire rescue plan into freefall.

The Energy Albatross

The biggest obstacle to recovery is BayWa r.e., the renewable energy division that was supposed to be the group’s crown jewel. US subsidy cuts for clean energy in early 2025 have hammered its valuation. Where management once projected EBITDA of €230 million by 2028, the current forecast is just €150 million — and that target has been pushed back to 2030. The division’s diminished prospects not only reduce any potential sale price but also make a sale structurally more difficult.

The fallout is reshaping the entire group. BayWa is cutting 1,300 jobs by 2027 and permanently closing 26 branches. The 2027 EBITDA target has been lowered to roughly €140 million, and the company has scrapped its full-year 2026 guidance entirely. Revenue is expected to settle at around €10 billion going forward.

Internal Controls Tighten

The supervisory board has responded by dramatically tightening oversight. The threshold for transactions requiring board approval has been slashed from €200 million to €50 million. Three board members — those internally blamed for the expansion strategy that led to the current crisis — are set to leave by spring 2027.

Meanwhile, investors are flying blind. BayWa will not publish its audited consolidated financial statements for 2025 until the fourth quarter of 2026, as the energy subsidiary requires revaluation. The previous auditor, PwC, is now under investigation by the German oversight body Apas. On May 6, the company will release its first-quarter 2026 report — the market’s first chance to see whether cost cuts are already lifting EBITDA.

Creditors Show Their Hand

How seriously lenders view the situation is evident from a concrete signal: Bavarian cooperative banks wrote down 60 percent of a Schuldschein loan in their 2024 annual accounts. In a worst-case scenario, total loss is on the table.

The next major asset on the block is T&G Global, BayWa’s New Zealand fruit subsidiary. Goldman Sachs is managing the sale, which analysts estimate could fetch around €300 million. A minority shareholder is complicating the process, however, and a quick deal is far from guaranteed.

BayWa shares traded at €14.50, roughly 32 percent below their 52-week high. On Tuesday, the stock jumped to €13.80 on news of the ongoing negotiations, but the year-to-date loss still stands at nearly 18 percent.

The company’s survival will be decided in a matter of months. If the core banks refuse to extend the standstill agreements this autumn, the StaRUG plan collapses. Until then, management must prove that the planned asset sales can actually deliver the billions needed — and that the cost cuts are more than just a stopgap.